thyroid cancer
Thyroid Cancer
... extra thyroid extension, and the size of the lesion by classifying patients in high risk or low risk groups for mortality ...Kettering Cancer Center group that resulted in the GAMES system (which included ...
54
CD133 as a Biomarker of Thyroid Cancer Stem Cells
... anaplastic thyroid cancer ...normal thyroid cells and cannot form the ...serum thyroid-stimulating hormone level and all presently valid treatment modalities (Bozorg-Ghalati and Hedayati, ...
8
Parathyroid involvement in thyroid cancer: an unforeseen event
... adjacent thyroid cancer in nine cases and metastasis to the parathyroid gland in one case with ...primary thyroid tumor had a median diameter of ...
5
Demographic and Pathological Characteristics of Thyroid Cancer in Libya
... malignant thyroid tumor in Libyan general population during (2000-2010) is relatively high ...years thyroid cancer incidence have been increased in Libya like in other North African countries, ...
12
ProNGF is a potential diagnostic biomarker for thyroid cancer
... including thyroid cancer as demonstrated in the present ...in thyroid tumors. Nerve fibers were seen in less than 5% of thyroid cancers and this was independent of proNGF expression (data not ...
10
Efficacy of lenvatinib in a patient with anaplastic thyroid cancer
... Most patients with anaplastic thyroid cancer (ATC) have a bulky neck tumor with cervicodynia, dyspnea, dysphagia, hoarseness and cough. More than 90% of patients have local infiltration to the great vessels ...
5
Role of vandetanib in the management of medullary thyroid cancer
... Medullary thyroid cancer (MTC) is a neuroendocrine tumor originating from parafollicular cells of the thyroid and which accounts for fewer than 10% of all diagnosed thyroid ...among ...
8
Selective use of sorafenib in the treatment of thyroid cancer
... medullary thyroid cancer (MTC), and two with poorly differentiated and ...differentiated thyroid cancer and ATC showed progressive disease ...
13
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis
... Abstract: Lymph node metastasis (LNM) is common in papillary thyroid cancer (PTC), and is an indicator of recurrence. The detailed molecular mechanism of LNM in PTC has not been well described. This study ...
13
Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management
... Clearly, development of rhTSH has dramatically changed the initial management and follow-up of patients with well-differentiated thyroid cancer. There is clear evidence that preparation of patients for RAI ...
16
I Radiotherapy of Pediatric Thyroid Cancer
... surgeon who performs over 100 thyroid cancer surgeries a year. A CXR at diagnosis was negative for pulmonary metastases and the lung fields on a pre-operative contrast- enhanced CT neck did not reveal ...
48
Next generation sequencing in thyroid cancer
... in thyroid cancer such as MITF, MDM2, JAK3, FLI1, IDH1 ...of thyroid cancer has not been delineated ...in thyroid cancer is ...in thyroid cancer is ...
10
RATIONAL MANAGEMENT OF DIFFERENTIATED THYROID CANCER
... of thyroid cancer can lead to long- term survival and cure, makes it prudent to conduct proper investigation of each case of suspected ...With thyroid scintigraphy, it is very easy to distinguish a ...
7
The treatment landscape in thyroid cancer: a focus on cabozantinib
... with thyroid cancer generally fare well, there is a subset for which this is not necessarily ...in thyroid cancer has led to a change in the management of these ...for thyroid ...
14
Serum biomarkers of papillary thyroid cancer
... including thyroid, colon and ...of thyroid cancer lesions, which was more pronounced in PTC than follicular carcinoma of the thyroid ...
10
Liquid Biopsy in Thyroid Cancer: New Insight
... medullary thyroid carcinoma (MTC) that develops from C cells in the thyroid gland, and is more aggressive and less differentiated than papillary or follicular cancers and sometimes is associated with ...
14
Graves's Disease Presenting Concurrently with Thyroid Cancer
... Jandee Lee, M.D., Kee-Hyun Nam, M.D., Chee-Young Lim, M.D., Jong-Ho Yoon, M.D. 1 , Hang-Seok Chang, M.D., Woong-Youn Chung and Cheong Soo Park, M.D. Purpose: Graves' disease presenting concurrently with thy- roid ...
7
FOLLICULAR EPITHELIAL cell-derived thyroid cancer
... in thyroid cancer cells ...of thyroid cancer cells harbor- ing mutant BRAF but not wild-type ...some thyroid cancer cells that harbored BRAF ...harboring thyroid ...
21
CUX2 functions as an oncogene in papillary thyroid cancer
... Background: In recent years, the incidence of thyroid cancer (TC), the most common endocrine malignancy, has been increasing. Emerging evidence indicates that the CUT/CUX/CDP family of proteins can play an ...
8
Evaluation of PACE4 isoforms as biomarkers in thyroid cancer
... Two hypothesis can be proposed to explain false-negative results for follicular variants of papillary carcinomas. First, genetic mutations from one subtype of thyroid cancer to the other are quite variable ...
11